A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
Conditions
- Coronary Artery Bypass Grafting (CABG)
- Chronic Heart Failure
- Chronic Ischemic Cardiomyopathy
Interventions
- DRUG: Mesenchymal stem cells(HucMSCs)
- PROCEDURE: CABG
Sponsor
Tasly Pharmaceutical Group Co., Ltd
Collaborators